Pre-treatment levels of circulating free IGF-1 identify NSCLC patients who derive clinical benefit from figitumumab
Gualberto, A; Hixon, M L; Karp, D D; Li, D; Green, S; Dolled-Filhart, M; Paz-Ares, L G; Novello, S; Blakely, J; Langer, C J; Pollak, M N
- 期刊名称British Journal of Cancer
- 作者Gualberto, A; Hixon, M L; Karp, D D; Li, D; Green, S; Dolled-Filhart, M; Paz-Ares, L G; Novello, S; Blakely, J; Langer, C J; Pollak, M N
- 卷第107卷
- 期第12期
- 印刷ISSN0007-0920
- 电子ISSN1532-1827
- 文件大小59.38KB
- 发表时间2012-12-04
- DOI10.1038/bjc.2012.497
- 页码2024-2024